[SLN] YoY Quarter Result on 31-Mar-2020 [#Q1]

Stock
[SLN] Silence Therapeutics plc
Announcement Date
30-Mar-2020
Financial Year
2020
Quarter
31-Mar-2020 [#Q1]
Profit Trend
QoQ- 3.01%
YoY- -34.35%
Quarter Report
SLN's Result
SLN's Financial Summary
View:
Show?
Quarter Result
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
Revenue 11,374 5,722 3,144 573 0 0 8 235.14%
PBT -12,673 -9,572 -9,870 -6,665 -4,799 -4,894 -3,328 24.95%
Tax -2,469 -1,888 -1,450 1,150 694 550 570 -
NP -10,204 -7,684 -8,420 -5,515 -4,105 -4,344 -2,758 24.35%
Tax Rate - - - - - - - -
Total Cost 21,578 13,406 11,564 6,088 4,105 4,344 2,766 40.80%
Ratio Analysis
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
NP Margin -89.71 -134.29 -267.81 -962.39 0.00 0.00 -34,475.00 -62.89%
Per Share
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
EPS -0.28 -0.26 -0.29 -0.21 -0.17 -0.19 -0.12 15.15%
EPS Diluted -0.28 -0.26 -0.29 -0.21 -0.17 -0.19 -0.12 15.15%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.